ISIS-SOD1Rx, an experimental therapy for patients with an inherited, aggressive form of Lou Gehrig's disease also known as familial amyotrophic lateral sclerosis (ALS), is currently undergoing phase 1 human studies, announced Isis Pharmaceuticals, the developer of the drug.

A diagnostic test for the most severe form of skin cancer melanoma may be soon on its way to markets.

Apixaban, an investigational oral anti blood clotting drug being developed by Bristol-Myers Squibb Company and Pfizer Inc has been found superior to Sanofi-Aventis' anti-coagulant enoxaparin (Lovenox).

Intas Pharmaceuticals, a mid-size generic firm from India, will conduct late phase clinical studies of Amarillo Biosciences' oral interferon-alpha lozenges in India.

Aurobindo Pharma Limited, one of the leading suppliers of APIs in India, has launched a contract manufacturing services division AuroSource to cater global pharma and biotech companies.

ImmunoVEXHSV2, an investigational vaccine against genital herpes developed by BioVex Inc, is undergoing first-in-man clinical studies.